WebMar 25, 2024 · Delcath Investor Relations Email: [email protected] Hayden IR James Carbonara (646)-755-7412 [email protected] Explore Investor Class Action Filed Against Olaplex Holdings, Inc... WebMar 27, 2024 · Delcath Systems Announces up to $85 Million Financing PR Newswire March 27, 2024, 8:15 AM · 6 min read Led by Vivo Capital with participation from Logos Capital, BVF Partners LP, Stonepine...

Delcath Systems Closes $20 Million Private Placement

WebOverview. Delcath Systems, Inc. (NASDAQ-DCTH) is an interventional oncology Company focused on the treatment of primary and metastatic liver cancers. Our investigational … Press Releases - Investors - Delcath Systems Inc. SEC Filings - Investors - Delcath Systems Inc. Contact us for more information about Delcath. Name (required) Email … WebDec 2, 2024 · Event: Delcath Systems Virtual Investor Update Meeting Date: Thursday, December 2, 2024 ... Delcath Investor Relations. Email: … cse beauregard

Delcath Systems Announces Move to a Direct Sales

WebDelcath Systems Announces $20 Million Private Placement . Roth Capital Partners is acting as the sole placement agent for the offering. After the placement agent fees and … WebOct 23, 2013 · Delcath Systems, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions herein, to issue and sell an aggregate of up to (i) 20,960,000 shares (the “Shares”) of its common stock, par value $0.01 per share (the “Common Stock”), and (ii) 9,432,000 warrants to purchase shares of Common Stock (the ... WebMar 2, 2024 · NEW YORK, March 02, 2024 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is... dyson pure cool me air purifier filter